Mologen’s experimental drug is found to be effective against colorectal cancer
MOLOGEN AG, a Berlin-based biotechnology company, has reported that an experimental drug, MGN1703, is found to be helpful in the
Read moreMOLOGEN AG, a Berlin-based biotechnology company, has reported that an experimental drug, MGN1703, is found to be helpful in the
Read more